Physician
J T Potter JR MD PC
J T Potter JR MD PC was paid $1.98M by Medicaid between Mar 2020 and Dec 2024, across 47 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 40% of everything it billed.
33Billing provider infoJ T POTTER JR MD PC
NORTON, VA 24273
NORTON, VA 24273
33aNPI1841216496assigned 07/15/2006
33bProvider typePediatric Adolescent Medicine Physician
28Total paid$1.98M
24GClaims47,276
24DCodes billed47
24AFirst – last monthMar 2020 – Dec 2024
Compared with peers
Next to other Pediatric Adolescent Medicine Physician providers in Virginia
Rank by total paid#4 of 30
Median peer was paid$29K
This provider vs. median68×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 3,845 | $177K | |
| 2021 | 10,699 | $466K | |
| 2022 | 10,608 | $512K | |
| 2023 | 11,425 | $457K | |
| 2024incomplete | 10,699 | $372K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 40% | 13,987 | 11,129 | $787K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14% | 3,603 | 3,157 | $278K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 8.5% | 2,456 | 2,310 | $168K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 8.3% | 6,168 | 5,285 | $165K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.6% | 4,050 | 2,610 | $72K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 3.3% | 256 | 239 | $66K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.2% | 869 | 810 | $63K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.0% | 751 | 711 | $60K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.2% | 635 | 574 | $43K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.1% | 557 | 475 | $42K |
| 95117 | 2.0% | 5,160 | 1,679 | $39K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.8% | 3,118 | 2,515 | $35K |
35 more codes
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.8% | 471 | $35K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 397 | $18K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 485 | $15K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 124 | $14K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 88 | $13K |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | <1% | 28 | $8K |
| 90686 | <1% | 516 | $5K | |
| 87634 | <1% | 85 | $5K | |
| M0222 | Intravenous injection, bebtelovimab, includes injection and post administration monitoring | <1% | 23 | $5K |
| 90670 | <1% | 364 | $4K | |
| 90734 | <1% | 315 | $4K | |
| 99384 | <1% | 47 | $4K | |
| 90651 | <1% | 252 | $3K | |
| 90671 | <1% | 216 | $3K | |
| 90723 | <1% | 223 | $3K | |
| 90620 | <1% | 183 | $2K | |
| 90710 | <1% | 202 | $2K | |
| 90647 | <1% | 219 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 61 | $2K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 28 | $2K |
| 87807 | <1% | 171 | $2K | |
| 99383 | <1% | 19 | $2K | |
| 90715 | <1% | 149 | $2K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 14 | $1K |
| 90633 | <1% | 134 | $1K | |
| 90680 | <1% | 125 | $1K | |
| 90697 | <1% | 105 | $1K | |
| Q3014 | Telehealth originating site facility fee | <1% | 42 | $836.85 |
| 36415 | Collection of venous blood by venipuncture | <1% | 363 | $745.55 |
| 90656 | <1% | 66 | $745.33 | |
| 90696 | <1% | 69 | $704.00 | |
| 0001A | <1% | 18 | $608.00 | |
| 83655 | <1% | 31 | $290.00 | |
| 90700 | <1% | 13 | $132.00 | |
| 85018 | <1% | 20 | $40.89 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPOTTER, JAMES (CEO)
| Provider | Location | Paid |
|---|---|---|
| Gulf Coast Molecular Laboratories, LLC | Spanish Fort, AL | $1.77M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.